NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New italian test aims to catch deadly swallowing problems earlier
Diagnosis CompletedThis study translated and tested an Italian version of a swallowing assessment tool for people with neurodegenerative diseases like Parkinson's and ALS. Swallowing problems (dysphagia) are common and can lead to serious complications like pneumonia. The goal is to provide Italian…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Diagnosis
Last updated Apr 03, 2026 14:42 UTC
-
Can watching videos help people with Parkinson's walk better?
Symptom relief CompletedThis study tested whether adding 'action observation therapy'—watching videos of specific movements—to standard physical exercises could help people with Parkinson's disease. It aimed to reduce episodes where walking suddenly freezes and to improve overall mobility. The trial inv…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Apr 04, 2026 06:37 UTC
-
Could intense workouts slow Parkinson's decline?
Symptom relief CompletedThis study tested whether a specific type of high-intensity exercise could help people with Parkinson's disease. Researchers compared a High-Intensity Functional Training (HIFT) program, which uses full-body movements like squats, to standard exercise programs. The goal was to se…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Valencia • Aim: Symptom relief
Last updated Apr 04, 2026 06:36 UTC
-
First human tests begin for potential brain disease drug
Knowledge-focused CompletedThis was an early-stage study to check the safety and see how the body processes a new drug called GV1001, which is being developed for brain diseases. It involved 59 healthy volunteers who received either the drug or a placebo as a single shot or multiple shots over several week…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE1 • Sponsor: GemVax & Kael • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC